C07C 309/29
Of non-condensed six-membered aromatic rings
Official title: of non-condensed six-membered aromatic rings
C07C309/29 (Of non-condensed six-membered aromatic rings) appears on 365 US grants and 520 published applications in this corpus.
Search patents in C07C- Granted patents
- 365
- Published applications
- 520
- Assignees
- 305
- Inventors
- 1,377
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 5 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 2 | 0 |
| 1981 | 0 | 0 |
| 1982 | 2 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 2 | 0 |
| 1986 | 2 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 2 | 0 |
| 1991 | 2 | 0 |
| 1992 | 4 | 0 |
| 1993 | 3 | 0 |
| 1994 | 2 | 0 |
| 1995 | 1 | 0 |
| 1996 | 3 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 3 | 0 |
| 2000 | 3 | 0 |
| 2001 | 5 | 1 |
| 2002 | 1 | 1 |
| 2003 | 3 | 3 |
| 2004 | 1 | 5 |
| 2005 | 3 | 7 |
| 2006 | 1 | 4 |
| 2007 | 2 | 16 |
| 2008 | 5 | 5 |
| 2009 | 5 | 8 |
| 2010 | 5 | 10 |
| 2011 | 5 | 5 |
| 2012 | 7 | 11 |
| 2013 | 12 | 23 |
| 2014 | 11 | 24 |
| 2015 | 29 | 33 |
| 2016 | 35 | 42 |
| 2017 | 26 | 35 |
| 2018 | 31 | 31 |
| 2019 | 27 | 29 |
| 2020 | 15 | 24 |
| 2021 | 15 | 25 |
| 2022 | 21 | 38 |
| 2023 | 13 | 37 |
| 2024 | 19 | 38 |
| 2025 | 17 | 32 |
| 2026 | 13 | 33 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Magnesium sulfonate detergent having improved compatibility with friction modifiers6 Oct 2026US 12,753,362 B2Afton Chemical Corporation
- Psilocybin analogs, salts, compositions, and methods of use15 Sep 2026US 12,735,386 B2Cybin IRL Limited
- Pharmaceutically acceptable salts of sepiapterin26 May 2026US 12,637,465 B2PTC Therapeutics MP, Inc.
- Salts of nitrogen-containing heterocyclic compound, and solid forms of salts, pharmaceutical composition and use thereof26 May 2026US 12,637,470 B2Wuhan Humanwell Innovative Drug Research and Development Center Limited Company
- Pyrrolidine amide derivative salt and use thereof19 May 2026US 12,630,507 B2Sunshine Lake Pharma Co., Ltd.
- Salt and crystal form of anti-tumor heterocyclic compound8 Oct 2026US 2026/0308143 A1Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd.
- Glycopyrrolate salts24 Sep 2026US 2026/0284007 A1Journey Medical Corporation
- Salt form and crystal form of thienopyrimidine compound, and preparation method therefor and use thereof24 Sep 2026US 2026/0285874 A1Shandong Luye Pharmaceutical Co., Ltd.
- Ammonium styrenesulfonate composition excellent in storage stability, and method for producing same17 Sep 2026US 2026/0274790 A1Sagami Chemical Research Institute
- Salt and solid forms of a cdk inhibitor17 Sep 2026US 2026/0274843 A1Genentech, Inc.
Most cited
By later US patents
- 4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)-1-(4-fluorophenyl)-1-butanone toluenesulfonic acid addition salt and salt crystals108US 8,648,077 B2Intra-Cellular Therapies, Inc. · 2014
- Crystalline forms of a purine derivative99US 8,889,861 B2Cyclacel Limited · 2014
- 4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)-1-(4-fluorophenyl)-1-butanone toluenesulfonic acid addition salt and salt crystals86US 9,199,995 B2Intra-Cellular Therapies, Inc. · 2015
- 4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de] quinoxalin-8(7H)-yl)-1-(4-fluorophenyl)-1-butanone toluenesulfonic acid salt crystal forms78US 9,586,960 B2Intra-Cellular Therapies, Inc. · 2017
- Functionalized ionic liquids, and methods of use thereof64US 7,208,605 B2University of South Alabama · 2007